TD Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$42.8K Buy
496
+3
+0.6% +$264 ﹤0.01% 265
2026
Q2
$38.6K Sell
493
-197
-29% -$15.9K ﹤0.01% 274
2026
Q1
$59.8K Buy
690
+125
+22% +$12K 0.01% 220
2025
Q4
$54.3K Buy
565
+410
+265% +$39.8K ﹤0.01% 224
2025
Q3
$14.8K Hold
155
– – ﹤0.01% 373
2025
Q2
$13.5K Buy
+155
New +$13.1K ﹤0.01% 377
2023
Q2
– Sell
-78
Closed -$6.26K – 419
2023
Q1
$6.26K Buy
78
+1
+1% +$82 ﹤0.01% 304
2022
Q4
$5.98K Buy
+77
New +$6.24K ﹤0.01% 285

Other funds holding MDT

TD Capital Management's MDT Position: Q3 2026 in Review

TD Capital Management increased its Medtronic (MDT) stake by 0.61% in Q3 2026, buying an estimated $264 and bringing the position to 496 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #265.

TD Capital Management first reported a position in MDT in Q4 2022 and has held it in 8 quarters since. The position peaked at $59.8K in Q1 2026. 2,202 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • TD Capital Management held 496 shares of Medtronic worth $42.8K as of Q3 2026.
  • TD Capital Management bought 3 Medtronic shares in Q3 2026, an estimated $264.
  • Medtronic made up ﹤0.01% of TD Capital Management's portfolio in Q3 2026, its #265 holding.
  • TD Capital Management first reported a position in Medtronic in Q4 2022 and has held it in 8 quarters since.
  • TD Capital Management's Medtronic position peaked at $59.8K in Q1 2026.
  • 2,202 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on TD Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.